Perspectives on Acquired Resistance to PD-1 Axis Inhibitors in Patients with Non-Small Cell Lung Cancer
J Thorac Oncol
.
2018 Jun;13(6):741-744.
doi: 10.1016/j.jtho.2018.04.008.
Authors
Diane Tseng
1
,
Sukhmani K Padda
1
,
Heather A Wakelee
2
Affiliations
1
Stanford Cancer Institute, Stanford University, Stanford, California.
2
Stanford Cancer Institute, Stanford University, Stanford, California. Electronic address: hwakelee@stanford.edu.
PMID:
29793645
DOI:
10.1016/j.jtho.2018.04.008
No abstract available
Publication types
Editorial
Comment
MeSH terms
B7-H1 Antigen
Carcinoma, Non-Small-Cell Lung*
Drug Resistance, Neoplasm
Humans
Lung Neoplasms*
Programmed Cell Death 1 Receptor
Substances
B7-H1 Antigen
Programmed Cell Death 1 Receptor